查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1800841

2025 年至 2033 年基因組學市場報告（按組件、應用、技術、最終用戶和地區分類）

Genomics Market Report by Component, Application, Technology, End-User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球基因體學市場規模達 384 億美元。展望未來， IMARC Group預計到 2033 年市場規模將達到 1,133 億美元，2025-2033 年期間的複合年成長率 (CAGR) 為 12.77%。市場的主要成長動力是新一代定序 (NGS) 在癌症等慢性疾病中擴大用於檢測基因異常，以及需要基因組定序的遺傳和病毒性疾病的盛行率上升。此外，基因組學領域尖端技術的引入正在增強應用和研究。再者，個人化醫療的使用日益增多，推動了對基於基因組資訊的客製化治療方案的需求，從而改善了患者的治療效果。

基因組學市場分析：

  • 主要市場促進因素：2025年基因組學市場規模將持續成長，這得益於基因定序技術的進步以及人們對個人化醫療日益成長的興趣。研發投入至關重要，將推動基因組學市場價值的上升。
  • 主要市場趨勢：人工智慧 (AI) 和機器學習 (ML) 在基因組學中的融合是基因組學市場的關鍵趨勢，有助於提升基因組學市場的研究能力。這一趨勢有助於完善預測模型，從而實現精準的基因組學市場預測。 CRISPR 基因編輯技術的採用凸顯了治療應用的重大轉變，直接影響基因組學市場的需求。
  • 地理趨勢：北美憑藉其先進的醫療基礎設施以及對研究和創新的高度重視，在基因組學市場收入方面佔據主導地位。受政府措施不斷增加以及基因組學研究日益受到重視的推動，亞太地區的基因組學市場成長率最高。這項擴張提供了多樣化的基因組學市場概況，預示著不同地區存在不同的成長前景。
  • 競爭格局：基因組學領域的知名市場參與者包括Illumina公司、賽默飛世爾科技、凱傑公司、安捷倫科技、牛津奈米孔技術公司和CRISPR Therapeutics等。這些實體對於基因組學市場前景至關重要，其競爭策略和創新為市場收入做出了巨大貢獻。
  • 挑戰與機會：與基因資料相關的倫理問題以及基因組定序的高昂成本為基因組學市場帶來了挑戰。然而，這些挑戰也為滿足日益成長的基因組學市場需求帶來了創新機會。開發經濟高效的定序方法並制定倫理準則，可以進一步提升基因組學市場的價值，並促進基因組學市場的成長。

基因組學市場趨勢：

定序技術的技術創新

根據基因組學市場分析，創新技術的快速進步，尤其是新一代定序 (NGS) 和 CRISPR-Cas9 基因組改造創新，是基因組學市場的重要驅動力。新興新創公司為診斷、個人化醫療和研究等多種用途提供定序服務。 NGS 等先進技術極大地改進了基因組分析，使其更快、更精確、更經濟。政府和產業資金對於市場成長、支持研究工作和創新技術商業化也至關重要。例如，23andMe（一家在消費者基因檢測領域佔據領先地位的公司）和 Genome Medical（最近獲得 1400 萬美元資金以增強其遠距醫療基因諮詢服務）等例子，凸顯了基因組學與醫療服務日益融合的趨勢。這些進步有助於使基因組學更易於獲取和使用，從而使 2025 年全球基因組學市場規模實現顯著成長。

個人化醫療需求不斷成長

推動市場發展的另一個重要驅動力是全球對個人化醫療日益成長的需求，個人化醫療是指根據每位患者的獨特特徵量身定做醫療方案。個人化醫療在很大程度上依賴基因資料，以便根據個人基因組成製定特定的療法，從而擺脫傳統醫學的泛泛之談，轉向更精準、更有效的治療方案。這也有助於提高消費者的認知度，幫助他們找到「基因組學市場是什麼？」這個問題的答案。此外，人們對疾病遺傳病因的認知和了解不斷加深、遺傳性疾病的發生率不斷上升，以及傳統療法對各種疾病的局限性，也推動了需求的不斷成長。在個人化醫療中運用基因組學旨在透過優先預防和精準治療來改善患者的治療效果，並提供經濟高效的醫療保健方案，從而推動基因組學領域的更多投資和研究。

臨床應用和診斷的擴展

基因組學技術在臨床應用和診斷領域的應用日益廣泛，例如識別遺傳疾病、癌症篩檢和監測傳染病，也推動了市場的成長。對疾病遺傳基礎的深入了解使得基因組學能夠融入臨床護理，從而催生出新的診斷工具和基因檢測，用於預測個體患特定疾病的風險、指導治療選擇並追蹤疾病進展。不禁要問：基因體學的需求究竟有多大，尤其是在臨床應用與診斷領域？基因組學技術的進步預計將繼續推動該領域的需求，拓展其在液體活體組織切片和非侵入性產前檢測 (NIPT) 等診斷領域的潛力，凸顯基因組學在醫療保健和診斷領域革新中的關鍵作用。

基因組學市場細分：

按組件細分：

  • 產品
    • 儀器和軟體
    • 耗材和試劑
  • 服務
    • 核心基因組學服務
    • 基於NGS的服務
    • 生物標記翻譯服務
    • 計算服務
    • 其他

耗材和試劑佔據大部分市場佔有率

耗材和試劑產業因其在DNA定序、基因編輯和樣品製備等各種基因組學程序中發揮的重要作用而佔據市場主導地位。隨著基因組學在醫療保健、農業和生物技術等領域的應用日益廣泛，對特定耗材和試劑的需求也日益成長，促使製造商不斷增強和擴展其產品範圍。這促進了耗材產業的發展，凸顯了其在推動和應用基因組學技術方面的關鍵作用，為市場的整體成長做出了重大貢獻。此外，這些產品對於確保研究和臨床診斷中基因組分析的準確性和可靠性至關重要，市場對這些產品的強勁需求進一步鞏固了該行業的主導地位。

按應用分類：

  • 功能基因體學
  • 表觀基因組學
  • 生物標記發現
  • 通路分析
  • 其他

功能基因組學佔據行業最大佔有率

功能基因組學專注於研究基因功能和相互作用，已成為市場主導領域，展現了其在理解複雜生物過程和疾病機制方面的關鍵作用。功能基因組學利用RNA定序和CRISPR-Cas9等高通量技術，能夠深入研究基因表現和調控，進而推動生物醫學研究和醫療保健領域的進步。此外，隨著技術快速進步，人們對探索基因組功能特徵的日益重視，使功能基因組學成為推動整個市場成長和創新的主要力量。

按技術分類：

  • 定序
  • 微陣列
  • 聚合酶鍊式反應
  • 核酸萃取與純化
  • 其他

測序代表著領先的細分市場

定序技術是市場的主要組成部分，因為它在解讀DNA和RNA中的遺傳訊息方面發揮著至關重要的作用，使其成為最大的技術領域。定序技術能夠揭示遺傳變異和突變，從而提供關鍵洞見，推動其在個人化醫療、遺傳研究和診斷應用領域中佔據重要地位。此外，新一代定序（NGS）技術的興起也正在改變這一領域，它比傳統技術擁有更快的速度、更高的準確性和更高的成本效益。新一代定序技術能夠對基因組、外顯子組和轉錄組進行詳細分析，進而推動對複雜疾病、演化生物學和微生物基因體學的理解。

按最終用戶分類：

  • 研究中心
  • 醫院和診所
  • 製藥和生物技術公司
  • 其他

製藥和生物技術公司在市場上佔據明顯主導地位

製藥和生技公司在市場中扮演著重要角色，強調其在推動藥物開發和個人化醫療方面的重要性。這些領域應用基因組資料來確定藥物的新標靶，了解疾病的遺傳起源，並利用個人基因資料開發客製化治療方案。例如，全球 DNA 定序和陣列技術的頂尖公司 Illumina Inc. 與范德堡大學醫學中心 (VUMC) 旗下著名的臨床和基因組資料公司 Nashville Biosciences, LLC 合作，揭曉了基因組發現聯盟 (AGD) 的五個創始成員。該擴展協議旨在透過進行徹底的基因組學研究和建立高品質的臨床基因組學資料庫來加快治療開發過程。 AbbVie、Amgen、AstraZeneca、Bayer 和 Merck 將集中資源資助 250,000 個樣本的定序，並可使用這些資料來開發藥物和改進療法。

按地區分類：

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

北美引領市場，佔據基因組學最大市場佔有率

該報告還對所有主要區域市場進行了全面分析，包括北美（美國和加拿大）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告指出，北美是基因組學最大的區域市場。

北美憑藉其先進的醫療保健體系、雄厚的研發投入以及頂尖製藥和生物技術公司的聚集，佔據了最大的市場佔有率。此外，該地區在基因組學和生物資訊學領域的先進技術，以及這些因素，為基因組學領域的發展和進步創造了良好的環境。北美在全球市場的強勢地位得益於學術和研究機構與產業界的密切合作，這促進了創新，並引領了影響全球基因組學實踐和政策的趨勢。

競爭格局：

市場研究報告還對市場競爭格局進行了全面分析，並提供了所有主要公司的詳細資料。基因組學行業的一些主要市場參與者包括

  • 23andMe公司
  • 安捷倫科技公司
  • 拜耳公司
  • 華大基因集團
  • Bio-Rad 實驗室公司
  • 丹納赫公司
  • Illumina公司
  • 牛津奈米孔技術公司
  • 珀金埃爾默公司
  • Myriad Genetics公司
  • F.霍夫曼-羅氏有限公司
  • 賽默飛世爾科技公司

產業主要參與者正積極進行各種策略活動，以維護和鞏固其市場地位。這些企業正在大力投資研發，以推出新的基因組技術、服務和解決方案，以滿足客戶不斷變化的需求。合作、建立夥伴關係和進行收購是重要的策略，有助於他們提昇技術能力、進入新市場並獲得新的基因組應用和智慧財產權。此外，這些頂尖公司正致力於改進其生物資訊系統，以管理和分析基因組定序產生的大量資料。這將有助於提供完整的解決方案，將基因組學發現轉化為臨床和農業領域的進步。

本報告回答的關鍵問題

  • 什麼是基因組學市場
  • 基因組學市場有多大
  • 基因組學的市場預測是什麼
  • 推動全球基因組學市場的關鍵因素有哪些
  • COVID-19 對全球基因組學市場有何影響
  • 全球基因組學市場按成分分類如何？
  • 根據應用，全球基因組學市場如何分類
  • 根據技術，全球基因組學市場如何分類
  • 根據最終用戶，全球基因組學市場如何分類
  • 10.全球基因體學市場的關鍵區域有哪些？
  • 11. 全球基因體學市場的主要參與者/公司有哪些？

本報告回答的關鍵問題

  • 基因組學市場是什麼？基因組學市場有多大？
  • 基因組學的市場預測如何？
  • 推動全球基因體學市場發展的關鍵因素有哪些？
  • COVID-19 對全球基因體學市場有何影響？
  • 根據組成部分，全球基因組學市場是如何分類的？
  • 根據應用，全球基因體學市場如何分佈？
  • 根據技術，全球基因組學市場如何分類？
  • 根據最終用戶，全球基因組學市場是如何分類的？
  • 全球基因組學市場的關鍵區域有哪些？
  • 全球基因組學市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

第5章：全球基因體學市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場細分：按組成部分

  • 產品
    • 主要類型
      • 儀器和軟體
      • 耗材和試劑
  • 服務
    • 主要類型
      • 核心基因組學服務
      • 基於NGS的服務
      • 生物標記翻譯服務
      • 計算服務
      • 其他

第7章：市場區隔：依應用

  • 功能基因體學
  • 表觀基因組學
  • 生物標記發現
  • 通路分析
  • 其他

第8章：市場區隔：依技術

  • 定序
  • 微陣列
  • 聚合酶鍊式反應
  • 核酸萃取與純化
  • 其他

第9章：市場區隔：依最終用戶

  • 研究中心
  • 醫院和診所
  • 製藥和生物技術公司
  • 其他

第10章：市場細分：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第 11 章：SWOT 分析

第 12 章：價值鏈分析

第 13 章：波特五力分析

第 14 章：價格指標

第 15 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • 23andMe, Inc.
    • Agilent Technologies, Inc.
    • Bayer Aktiengesellschaft
    • BGI Genomics Co. Ltd.
    • Bio-RAD Laboratories Inc.
    • Danaher Corporation
    • Illumina Inc.
    • Oxford Nanopore Technologies
    • PerkinElmer Inc.
    • Myriad Genetics Inc.
    • Roche Holding AG
    • Thermo Fisher Scientific Inc.
Product Code: SR112025A2246

The global genomics market size reached USD 38.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 113.3 Billion by 2033, exhibiting a growth rate (CAGR) of 12.77% during 2025-2033. The market's main growth drivers are the increasing use of next-generation sequencing (NGS) in chronic diseases like cancer to detect genetic abnormalities and the rise in the prevalence of hereditary and viral disorders that require genomic sequencing. Additionally, the introduction of cutting-edge technologies in the genomics sector is enhancing applications and research. Furthermore, patient outcomes are being improved by the growing use of personalized medicine, which is driving the need for customized treatment regimens based on genomic information.

Genomics Market Analysis:

  • Major Market Drivers: The genomics market size 2025 is experiencing growth driven by advancements in genetic sequencing technologies and an increasing interest in personalized medicine. Investments in R&D are pivotal, pushing the genomics market value upwards.
  • Key Market Trends: Artificial intelligence (AI) and machine learning (ML) integration in genomics refer to the key genomics market trends, enhancing genomics market research capabilities. This trend aids in refining predictive modeling, leading to precise genomics market forecasts. The adoption of CRISPR gene editing technology highlights a significant shift in therapeutic applications, directly influencing genomics market demand.
  • Geographical Trends: North America dominates in terms of genomics market revenue, due to its advanced healthcare infrastructure and a strong focus on research and innovation. The Asia-Pacific region shows the fastest genomics market growth rate, propelled by increasing government initiatives and a burgeoning focus on genomics research. This expansion offers a diverse genomics market overview, signaling varied growth prospects across different regions.
  • Competitive Landscape: Notable market players in the genomics sector include Illumina, Inc., Thermo Fisher Scientific, QIAGEN, Agilent Technologies, Oxford Nanopore Technologies, and CRISPR Therapeutics, among others. These entities are crucial in determining the genomics market outlook, with their competitive strategies and innovations significantly contributing to the market revenue.
  • Challenges and Opportunities: Ethical concerns related to genetic data and the high costs associated with genomic sequencing pose challenges in the genomics market. Yet, these challenges also unveil opportunities for innovation to meet the increasing genomics market demand. Developing cost-effective sequencing methods and establishing ethical guidelines could further bolster the genomics market value and facilitate genomics market growth.

Genomics Market Trends:

Technological innovations in sequencing technologies

According to the genomics market analysis, the fast pace of innovative advancements, especially in next-generation sequencing (NGS) and CRISPR-Cas9 genome altering innovations, serves as an essential driver for the genomics showcase. The emergence of startups providing sequencing services for diverse uses, such as diagnostics, personalized medicine, and research. Sophisticated technologies like NGS have greatly improved genomic analysis, ensuring it is quicker, more precise, and economical. Government and industry funding are also vital in growing the market, aiding research efforts and the commercialization of innovative technologies. Examples like 23andMe, a prominent player in consumer genetic testing, and Genome Medical, which recently obtained $14 million in funding to enhance its telehealth genetic consultations, underscore the growing fusion of genomics and healthcare services. These advancements contribute to making genomics more attainable and usable, thereby making the global genomics market size 2025 experience significant growth.

Growing demand for personalized medicine

Another important driver of the market is the rising across the globe need for personalized medicine, which customizes medical care according to each patient's unique characteristics. Customized medical treatment depends greatly on genetic data to inform the creation of specific therapies tailored to an individual's genetic composition, moving away from the generalized approach of traditional medicine to more accurate and efficient treatments. This also facilitates enhanced awareness among consumers that helps them find an answer for the "what is the genomics market?" question. Along with this, the increasing need is fueled by the expanding recognition and knowledge of the genetic causes of diseases, the increasing frequency of genetic conditions, and the limitations of conventional therapies for various illnesses. Using genomics in personalized medicine aims to enhance patient results and provides a cost-effective healthcare approach by prioritizing prevention and accurate treatment, which drives more investments and research in genomics.

Expansion in clinical applications and diagnostics

The market is also growing due to genomics technologies being utilized more for clinical applications and diagnostics, such as identifying genetic disorders, cancer screening, and monitoring infectious diseases. Improved understanding of the genetic basis of diseases has allowed for the incorporation of genomics into clinical care, resulting in the creation of novel diagnostic tools and genetic tests that can anticipate an individual's risk for specific conditions, guide treatment choices, and track disease advancement. A question arises, what is the demand for genomics, particularly in the field of clinical applications and diagnostics? Advancements in genomics technologies are anticipated to keep driving demand in this field, expanding their potential in diagnostics such as liquid biopsies and NIPT, highlighting the critical role genomics plays in revolutionizing healthcare and diagnostics.

Genomics Market Segmentation:

Breakup by Component:

  • Products
    • Instruments and Software
    • Consumables and Reagents
  • Services
    • Core Genomics Services
    • NGS-Based Services
    • Biomarker Translation Services
    • Computational Services
    • Others

Consumables and reagents account for the majority of the market share

The consumables and reagents sector dominates the market due to their essential role in a variety of genomic procedures including DNA sequencing, gene editing, and sample preparation. With the increased use of genomics in sectors such as healthcare, agriculture, and biotechnology, there is a rising need for specific consumables and reagents, leading manufacturers to enhance and extend their product range. This is promoting the development of the consumables industry, emphasizing its crucial role in driving and applying genomics technologies, making a substantial contribution to the market's overall growth. Moreover, the strong demand for these products, which are essential for ensuring the accuracy and reliability of genomic analyses in research and clinical diagnostics, further solidifies the dominance of this industry sector.

Breakup by Application:

  • Functional Genomics
  • Epigenomics
  • Biomarkers Discovery
  • Pathway Analysis
  • Others

Functional genomics holds the largest share of the industry

Functional genomics, which focuses on gene functions and interactions, has become the dominant area in the market, showcasing its crucial importance in comprehending intricate biological processes and disease mechanisms. Utilizing high-throughput technologies including RNA sequencing and CRISPR-Cas9 in functional genomics enables in-depth study of gene expression and regulation, leading to progress in biomedical research and healthcare. Moreover, the growing emphasis on exploring the functional characteristics of the genome, along with the quick advancements in technology, positions functional genomics as a major force driving growth and innovation in the overall market.

Breakup by Technology:

  • Sequencing
  • Microarray
  • Polymerase Chain Reaction
  • Nucleic Acid Extraction and Purification
  • Others

Sequencing represents the leading market segment

Sequencing technology is the main component of the market due to its crucial role in deciphering the genetic information found in DNA and RNA, making it the largest technological segment. The critical insights provided by sequencing drive this prominence in personalized medicine, genetic research, and diagnostic applications by uncovering genetic variations and mutations. Furthermore, the rise of NGS technologies is changing this field by offering unparalleled speed, accuracy, and cost-efficiency compared to traditional techniques. NGS enables a detailed analysis of genomes, exomes, and transcriptomes, allowing for progress in comprehending complex diseases, evolutionary biology, and microbial genomics.

Breakup by End-User:

  • Research Centers
  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Companies
  • Others

Pharmaceutical and biotechnology companies exhibit a clear dominance in the market

Pharmaceutical and biotechnology companies are playing a major role in the market, emphasizing their significance in driving drug development and personalized medicine forward. These areas apply genomic data to identify novel targets for drugs, understand the genetic origins of diseases, and develop tailored treatments using individuals' genetic data. For instance, Illumina Inc., a top company in DNA sequencing and array-based technologies worldwide, partnered with Nashville Biosciences, LLC, a prominent clinical and genomic data company that is a subsidiary of Vanderbilt University Medical Center (VUMC), to reveal the five original members of the Alliance for Genomic Discovery (AGD). The extended agreement aims to quicken the treatment development process by conducting thorough genomics research and establishing a high-quality clinical genomics database. AbbVie, Amgen, AstraZeneca, Bayer, and Merck will pool their resources to fund the sequencing of 250,000 samples and can use the data for developing drugs and improving therapies.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest genomics market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for genomics.

North America holds the largest market share due to its advanced healthcare system, significant investment in research and development, and the presence of top pharmaceutical and biotechnology companies. Additionally, the region's advanced technology in genomics and bioinformatics, along with these factors, is fostering a favorable environment for the development and advancement of the genomics field. North America's strong position in the global market is supported by the close collaboration between academic and research institutions with the industry, leading to innovation and setting trends that impact global genomics practices and policies.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the genomics industry include

  • 23andMe, Inc
  • Agilent Technologies, Inc.
  • Bayer AG
  • BGI Group
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Illumina, Inc.
  • Oxford Nanopore Technologies
  • PerkinElmer, Inc.
  • Myriad Genetics, Inc.
  • F. Hoffmann-La Roche Ltd
  • Thermo Fisher Scientific Inc.

Major players in the industry are involved in various strategic activities to uphold and strengthen their market presence. These businesses are making significant investments in research and development to launch new genomic technologies, services, and solutions that cater to their customers' changing needs. Working together, forming partnerships, and making acquisitions are important strategies that enable them to enhance their technological capabilities, enter new markets, and gain new genomic applications and intellectual property. Additionally, these top companies are focusing on improving their bioinformatics systems to manage and analyze the large amounts of data generated from genomic sequencing. This enables full solutions that help translate genomic findings into progress in clinical and agricultural sectors.

Key Questions Answered in This Report

  • 1.What is the genomics market?
  • 2.How big is the genomics market?
  • 3.What is the market forecast for genomics?
  • 4.What are the key factors driving the global genomics market?
  • 5.What has been the impact of COVID-19 on the global genomics market?
  • 6.What is the breakup of the global genomics market based on the component?
  • 7.What is the breakup of the global genomics market based on the application?
  • 8.What is the breakup of the global genomics market based on the technology?
  • 9.What is the breakup of the global genomics market based on the end-user?
  • 10.What are the key regions in the global genomics market?
  • 11.Who are the key players/companies in the global genomics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Genomics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Component

  • 6.1 Products
    • 6.1.1 Market Trends
    • 6.1.2 Major Types
      • 6.1.2.1 Instruments and Software
      • 6.1.2.2 Consumables and Reagents
    • 6.1.3 Market Forecast
  • 6.2 Services
    • 6.2.1 Market Trends
    • 6.2.2 Major Types
      • 6.2.2.1 Core Genomics Services
      • 6.2.2.2 NGS-Based Services
      • 6.2.2.3 Biomarker Translation Services
      • 6.2.2.4 Computational Services
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Functional Genomics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Epigenomics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Biomarkers Discovery
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Pathway Analysis
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 Sequencing
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Microarray
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Polymerase Chain Reaction
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Nucleic Acid Extraction and Purification
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Research Centers
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Hospitals and Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Pharmaceutical and Biotechnology Companies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Indicators

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 23andMe, Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Agilent Technologies, Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bayer Aktiengesellschaft
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 BGI Genomics Co. Ltd.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 Bio-RAD Laboratories Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Danaher Corporation
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Illumina Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Oxford Nanopore Technologies
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 PerkinElmer Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Myriad Genetics Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Roche Holding AG
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
    • 15.3.12 Thermo Fisher Scientific Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Genomics Market: Major Drivers and Challenges
  • Figure 2: Global: Genomics Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Genomics Market: Breakup by Component (in %), 2024
  • Figure 4: Global: Genomics Market: Breakup by Application (in %), 2024
  • Figure 5: Global: Genomics Market: Breakup by Technology (in %), 2024
  • Figure 6: Global: Genomics Market: Breakup by End-User (in %), 2024
  • Figure 7: Global: Genomics Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Genomics Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 9: Global: Genomics (Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Genomics (Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Genomics (Services) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Genomics (Services) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Genomics (Functional Genomics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Genomics (Functional Genomics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Genomics (Epigenomics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Genomics (Epigenomics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Genomics (Biomarkers Discovery) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Genomics (Biomarkers Discovery) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Genomics (Pathway Analysis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Genomics (Pathway Analysis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Genomics (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Genomics (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Genomics (Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Genomics (Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Genomics (Microarray) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Genomics (Microarray) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Genomics (Polymerase Chain Reaction) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Genomics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Genomics (Nucleic Acid Extraction and Purification) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Genomics (Nucleic Acid Extraction and Purification) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Genomics (Other Technologies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Genomics (Other Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Genomics (Research Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Genomics (Research Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Genomics (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Genomics (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Global: Genomics (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Global: Genomics (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Global: Genomics (Other End-Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Global: Genomics (Other End-Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: North America: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: North America: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: United States: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: United States: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Canada: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Canada: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Asia Pacific: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Asia Pacific: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: China: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: China: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Japan: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Japan: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: India: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: India: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: South Korea: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: South Korea: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Australia: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Australia: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Indonesia: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Indonesia: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Others: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Others: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Europe: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Europe: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Germany: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Germany: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: France: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: France: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: United Kingdom: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: United Kingdom: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Italy: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Italy: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Spain: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Spain: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Russia: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Russia: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Others: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Others: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Latin America: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Latin America: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Brazil: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Brazil: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Mexico: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Mexico: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Others: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 86: Others: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Middle East and Africa: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 88: Middle East and Africa: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 89: Global: Genomics Industry: SWOT Analysis
  • Figure 90: Global: Genomics Industry: Value Chain Analysis
  • Figure 91: Global: Genomics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Genomics Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Genomics Market Forecast: Breakup by Component (in Million USD), 2025-2033
  • Table 3: Global: Genomics Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Genomics Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 5: Global: Genomics Market Forecast: Breakup by End-User (in Million USD), 2025-2033
  • Table 6: Global: Genomics Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Genomics Market: Competitive Structure
  • Table 8: Global: Genomics Market: Key Players